BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Takeda Pharmaceutical Co Ltd (TAK) investor events
X-WR-CALNAME:Takeda Pharmaceutical Co Ltd (TAK) investor events
DESCRIPTION:Earnings calls and investor events for Takeda Pharmaceutical Co
  Ltd (TAK)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Takeda Pharmaceutical C
 o Ltd (TAK)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:38472cd0-7783-478a-bb07-bebca8fbda7a@equibles.com
DTSTAMP:20260801T124916Z
DTSTART;VALUE=DATE:20260129
DTEND;VALUE=DATE:20260130
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Takeda Pharmaceutical Co Ltd (TAK) Earnings Call\, FY2026 Q3
DESCRIPTION:The start time has not been announced.\nWebcast: https://event.
 summitcast.com/view/NgCqua4VVQjq9ibVWHVWca/VCtwWGsEfwZGREbdeQob2L
URL:https://equibles.com/stocks/tak/calls/2026-q3
END:VEVENT
BEGIN:VEVENT
UID:ed7a4f8c-9924-4a10-8cf7-0c2c1af0e6b0@equibles.com
DTSTAMP:20260820T160331Z
DTSTART;VALUE=DATE:20260513
DTEND;VALUE=DATE:20260514
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Takeda Pharmaceutical Co Ltd (TAK) Earnings Call\, FY2026 Q4
DESCRIPTION:The start time has not been announced.\nWebcast: https://www.ta
 keda.com/investors/financial-results/
URL:https://equibles.com/stocks/tak/calls/2026-q4
END:VEVENT
BEGIN:VEVENT
UID:ace93267-4e9b-4ad7-aa45-ec0222b01918@equibles.com
DTSTAMP:20260730T104526Z
DTSTART;VALUE=DATE:20260730
DTEND;VALUE=DATE:20260731
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Takeda Pharmaceutical Co Ltd (TAK) Earnings Call\, FY2027 Q1
DESCRIPTION:The start time has not been announced.\nWebcast: https://www.ta
 keda.com/investors/financial-results/quarterly-results/
URL:https://equibles.com/stocks/tak/calls/2027-q1
END:VEVENT
BEGIN:VEVENT
UID:b143b8a5-3a93-494a-b9fd-75994036244f@equibles.com
DTSTAMP:20261029T192033Z
DTSTART;VALUE=DATE:20261029
DTEND;VALUE=DATE:20261030
SEQUENCE:26076033
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Takeda Pharmaceutical Co Ltd (TAK) Earnings Call\, FY2027 Q2
DESCRIPTION:The start time has not been announced.
URL:https://equibles.com/stocks/tak/calls/2027-q2
END:VEVENT
END:VCALENDAR
